King & Spalding's Trial Successes in 2024

This article is a report detailing the achievements of King & Spalding LLP's trial team in 2024, highlighting their defense of major clients such as Boehringer Ingelheim and Johnson & Johnson. The firm successfully defended Boehringer Ingelheim in a high-profile case regarding Zantac, where jurors found that the drug did not cause a woman's cancer. The report emphasizes the firm's focus on litigation, with over 550 lawyers dedicated to trials and disputes. Additionally, it outlines their victory for Johnson & Johnson in talcum powder litigation, where the jury ruled in favor of the company after a brief deliberation. The article also discusses the firm's international successes, including a $900 million settlement for Colombia's Refineria de Cartagena in complex multijurisdictional cases. The report concludes by noting the firm's growing demand and reputation in handling significant legal challenges across various jurisdictions.